INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
ME
Michael ElsaDirector
GESGUESS INC
Other acquisition or disposition
J$130K
7,735 sh
Jan 23, 2026Jan 27, 2026
Page 1391 of 1786
← PrevNext →
traded Jan 23, 2026
+4d
SEC Form 4

Evidence

27
RM
Ramani MohitChief Risk Officer
KEYKEYCORP /NEW/
Tax withholding
F$445K
21.1K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

27
LN
Lewis Christopher N.Director
GESGUESS INC
Other acquisition or disposition
J$82K
4,914 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

26
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Tax withholding
F$1.88M
1,966 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

25
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$110K
23.8K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

25
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$124K
26.9K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

24
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

24
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Grant or award
A—
6,043 sh
Oct 7, 2025Jan 27, 2026
traded Oct 7, 2025
+112dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$144K
524 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
EA
Eidson Charles AndrewDirector, Chief Executive Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$846K
3,662 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$119K
429 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
WE
Whitehead Jason E.President & COO
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$587K
2,541 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

23
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$117K
421 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

23
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$74K
263 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

23
MT
Munsey Joshua ToddChief Financial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$350K
1,515 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

23
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$64K
227 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

22
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Tax withholding
F$2.36M
2,467 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

22
A
A-6684 Ltd.10% Owner
TOFBTOFUTTI BRANDS INC
Open-market purchase
BUY$3,439
4,525 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
VM
VanHimbergen Robert MEVP and CFO
ELANElanco Animal Health Inc
Grant or award
A$190
8 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
RM
Ramani MohitChief Risk Officer
KEYKEYCORP /NEW/
Option exercise
M—
61.5K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
RK
Robinson KatrinaDirector
MCBMetropolitan Bank Holding Corp.
Grant or award
A—
2,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
5,482 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
MB
Murray BrianDirector
BTGOBITGO HOLDINGS, INC.
Derivative conversion
C—
1,675 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
BF
Benarouche FabriceSVP Finance and IR, CAO
GESGUESS INC
Other acquisition or disposition
J$1.57M
93.9K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
4,034 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

21
AV
Abate VictorChief Executive Officer, Wind
GEVGE Vernova Inc.
Grant or award
A—
1,163 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

20
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$145K
514 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$30K
107 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$3,360
12 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$283
1 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$17K
62 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

19
HE
Horn Daniel E.Chief Commercial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$370K
1,600 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

18
BF
Benarouche FabriceSVP Finance and IR, CAO
GESGUESS INC
Other acquisition or disposition
J$450K
26.9K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
WD
Weinswig DeborahDirector
GESGUESS INC
Other acquisition or disposition
J$451K
26.9K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
TM
Toni Alberto Michele MariaCFO
GESGUESS INC
Other acquisition or disposition
J$557K
33.3K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M—
21.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
HJ
Hoff Brian JosephChief Financial Officer
UMACUnusual Machines, Inc.
Grant or award
A—
110.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence